{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:12:40Z","timestamp":1790993560457,"version":"4.1.0"},"reference-count":58,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"4","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Vitiligo is an autoimmune disorder with a complex genetic and epigenetic aetiology, characterised by progressive skin depigmentation. Recent advancements in artificial intelligence (AI) have greatly impacted the understanding, diagnosis, and treatment of vitiligo. The genetic basis of vitiligo is linked to multiple single nucleotide polymorphisms (SNPs) in genes associated with immune function, apoptosis, and melanogenesis, necessitating the integration of AI for more efficient diagnostic tools and personalised therapies. Genome-wide association studies (GWAS) have identified approximately 50 vitiligo-susceptibility genes, including PTPN1, PTPN22, NLRP1, FASLG, and TYR. These genes influence the immune response and melanocyte function, with the transcription factor Nuclear Factor kappa B (NF-kB), playing a central role in inflammatory responses and redox signaling induced by oxidative stress, in conjunction with antioxidant enzymes such as GPx, GST, SOD, and CAT. AI technologies offer a promising avenue for diagnosing vitiligo by combining genetic, clinical, and imaging data, allowing for more accurate classification and personalised treatment strategies. By analysing vast datasets, AI algorithms can identify patterns within complex genetic markers and clinical features, facilitating earlier and more precise detection of vitiligo. Furthermore, AI-driven approaches can optimise therapeutic monitoring, enabling real-time treatment efficacy and disease progression assessment. Integrating AI in vitiligo genetic diagnostics can revolutionise the monitoring of the disorder, improving patient outcomes through personalised, data-driven interventions.<\/jats:p>","DOI":"10.5937\/jomb0-56661","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:40:09Z","timestamp":1741668009000},"page":"713-723","source":"Crossref","is-referenced-by-count":3,"title":["Unraveling genetic predisposition and oxidative stress in vitiligo development and the role of artificial intelligence (AI) in diagnosis and management"],"prefix":"10.5937","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9667-5798","authenticated-orcid":false,"given":"Hristina","family":"Koci\u0107","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01strh679","id-type":"ROR","asserted-by":"publisher"}]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torello","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0600-5411","authenticated-orcid":false,"given":"Tatjana","family":"Jevtovi\u0107-Stoimenov","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00965bg92","id-type":"ROR","asserted-by":"publisher"}]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Wollina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9796-3433","authenticated-orcid":false,"given":"Stevo","family":"Luki\u0107","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00965bg92","id-type":"ROR","asserted-by":"publisher"}]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-0996","authenticated-orcid":false,"given":"Aleksandra","family":"Klisi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bertolani M, Rodighiero E, de Felici Del Giudice MB, Lotti T, Feliciani C, Satolli F. Vitiligo: What's old, what's new. Dermatol Reports 2021; 13(2): 9142. doi: 10.4081\/dr.2021.9142. PMID: 34659674;","DOI":"10.4081\/dr.2021.9142"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Lotti T, D'Erme AM. Vitiligo as a systemic disease. Clin Dermatol 2014; 32(3): 430-4. doi: 10.1016\/j.clindermatol.2013.11.011;","DOI":"10.1016\/j.clindermatol.2013.11.011"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol 2012; 51(10): 1206-12. doi: 10.1111\/j.1365-4632.2011.05377.x;","DOI":"10.1111\/j.1365-4632.2011.05377.x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Akl J, Lee S, Ju HJ, Parisi R, Kim JY, Jeon JJ, Heo YW, Eleftheriadou V, Hamzavi I, Griffiths CEM, Ashcroft DM, Mysore V, Gupta S, Parsad D, Lim H, Bae JM, Ezzedine K; Global Vitiligo Atlas. Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health 2024; 9(6): e386-e396. doi: 10.1016\/S2468-2667(24)00026-4;","DOI":"10.1016\/S2468-2667(24)00026-4"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Ta\u00efeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA. Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalised vitiligo age of onset. J Invest Dermatol 2011; 131(6): 1308-12. doi: 10.1038\/jid.2011.12;","DOI":"10.1038\/jid.2011.12"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Said-Fernandez SL, Sanchez-Dom\u00ednguez CN, Salinas-Santander MA, Martinez-Rodriguez HG, Kubelis-Lopez DE, Zapata-Salazar NA, Vazquez-Martinez OT, Wollina U, Lotti T, Ocampo-Candiani J. Novel immunological and genetic factors associated with vitiligo: A review. Exp Ther Med 2021; 21(4): 312. doi: 10.3892\/etm.2021.9743;","DOI":"10.3892\/etm.2021.9743"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Marzano AV, Alberti-Violetti S, Maronese CA, Avallone G, Jommi C. Vitiligo: Unmet Need, Management and Treatment Guidelines. Dermatol Pract Concept 2023; 13(4S2): e2023316S. doi: 10.5826\/dpc.1304S2a316S;","DOI":"10.5826\/dpc.1304S2a316S"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wang Z, Xue Y, Liu Z, Wang C, Xiong K, Lin K, Ou J, Zhang J. AI fusion of multisource data identifies key features of vitiligo. Sci Rep 2024; 14(1): 24278. doi: 10.1038\/s41598-024-75062-4;","DOI":"10.1038\/s41598-024-75062-4"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Li Pomi F, Papa V, Borgia F, Vaccaro M, Pioggia G, Gangemi S. Artificial Intelligence: A Snapshot of Its Application in Chronic Inflammatory and Autoimmune Skin Diseases. Life (Basel) 2024; 14(4): 516. doi: 10.3390\/life14040516;","DOI":"10.3390\/life14040516"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Clemente Hern\u00e1ndez B, Muelas Rives I, Gracia Caza\u00f1a T, \u00c1lvarez Salafranca M, Poblador-Plou B, Laguna-Berna C, Moreno Juste A, Gimeno-Miguel A, Gilaberte Y. Comorbidities Associated with Vitiligo: Results from the EpiChron Cohort. J Clin Med 2025; 14(2): 432. doi: 10.3390\/jcm14020432. PMID: 39860439;","DOI":"10.3390\/jcm14020432"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Karagaiah P, Schwartz RA, Lotti T, Wollina U, Grabbe S, Goldust M. Biologic and targeted therapeutics in vitiligo. J Cosmet Dermatol 2023; 22(1): 64-73. doi: 10.1111\/jocd.14770;","DOI":"10.1111\/jocd.14770"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Dong ZY, He MJ, Yu YK, Wang F, Zhao PY, Ran DL, Fu DS, He Q, Yang RP, Zhang JA. Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS. Sci Rep 2025; 15(1): 2245. doi: 10.1038\/s41598-025-86134-4;","DOI":"10.1038\/s41598-025-86134-4"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Hillmer D, Merhi R, Boniface K, Taieb A, Barnetche T, Seneschal J, Hagedorn M. Evaluation of Facial Vitiligo Severity with a Mixed Clinical and Artificial Intelligence Approach. J Invest Dermatol 2024; 144(2): 351-7. e4. doi: 10.1016\/j.jid.2023.07.014;","DOI":"10.1016\/j.jid.2023.07.014"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Guo L, Yang Y, Ding H, Zheng H, Yang H, Xie J, Li Y, Lin T, Ge Y. A deep learning-based hybrid artificial intelligence model for the detection and severity assessment of vitiligo lesions. Ann Transl Med 2022; 10(10): 590. doi: 10.21037\/atm-22-1738;","DOI":"10.21037\/atm-22-1738"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Liu Y, Jain A, Eng C, et al. A deep learning system for differential diagnosis of skin diseases. Nat Med 2020; 26: 900-8. doi: 10.1038\/s41591-020-0842-3;","DOI":"10.1038\/s41591-020-0842-3"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Tembhre MK, Shipra. Low-Dose Melittin Enhanced Pigment Production Through the Upregulation of Tyrosinase Activity and Dendricity in Melanocytes by Limiting Oxidative Stress: A Therapeutic Implication for Vitiligo. Antioxidants (Basel) 2024; 13(11): 1424. doi: 10.3390\/antiox13111424;","DOI":"10.3390\/antiox13111424"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Lotti T, Gianfaldoni S, Valle Y, Rovesti M, Feliciano C, Satolli F. Controversial issues in vitiligo patients: a review of old and recent treatments. Dermatol Ther 2019; 32(1): e12745. doi: 10.1111\/dth.12745;","DOI":"10.1111\/dth.12745"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Xuan Y, Yang Y, Xiang L, Zhang C. The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death. Oxid Med Cell Longev 2022; 2022: 8498472. doi: 10.1155\/2022\/8498472;","DOI":"10.1155\/2022\/8498472"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Chang WL, Ko CH. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications. Cells 2023; 12(6): 936. doi: 10.3390\/cells12060936;","DOI":"10.3390\/cells12060936"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Jung E, Kim JH, Kim MO, Lee SY, Lee J. Melanocyte-protective effect of afzelin is mediated by the Nrf2-ARE signalling pathway via GSK-3 inactivation. Exp Dermatol 2017; 26(9): 764-70. doi: 10.1111\/exd.13277;","DOI":"10.1111\/exd.13277"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Lin X, Meng X, Song Z, Lin J. Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo. Arch Biochem Biophys 2020; 696: 108670. doi: 10.1016\/j.abb.2020.108670;","DOI":"10.1016\/j.abb.2020.108670"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16(3): 208-14;","DOI":"10.1034\/j.1600-0749.2003.00032.x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Birlea SA, LaBerge GS, Procopciuc LM, Fain PR, Spritz RA. CTLA4 and generalised vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res 2009; 22(2): 230-4;","DOI":"10.1111\/j.1755-148X.2009.00543.x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"LaBerge GS, Bennett DC, Fain PR, Spritz RA. PTPN22 is genetically associated with risk of generalised vitiligo, but CTLA4 is not. J Investig Dermatol 2008; 128: 1757-62;","DOI":"10.1038\/sj.jid.5701233"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007; 356(12): 1216-25;","DOI":"10.1056\/NEJMoa061592"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Spritz RA, Andersen GH. Genetics of Vitiligo. Dermatol Clin 2017; 35(2): 245-55. doi: 10.1016\/j.det.2016.11.013;","DOI":"10.1016\/j.det.2016.11.013"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M, Molinelli E, Offidani A, Simonetti O. Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art. Int J Mol Sci 2023; 24(5): 4910. doi: 10.3390\/ijms24054910;","DOI":"10.3390\/ijms24054910"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T, Taddei N. The involvement of Smac\/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: Protective effects of curcumin and capsaicin. Antioxid Redox Signal 2010; 13(9): 1309-21. doi: 10.1089\/ars.2009.2779;","DOI":"10.1089\/ars.2009.2779"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"AbdElneam AI, Al-Dhubaibi MS, Bahaj SS, Mohammed GF, Atef LM. Identification of Upregulating Genes, Transcription Factors, and miRNAs in Vitiligo. In silico Study. Clin Cosmet Investig Dermatol 2024; 17: 2123-39. doi: 10.2147\/CCID.S480990;","DOI":"10.2147\/CCID.S480990"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Jin Y, Riccardi SL, Gowan K, Fain PR, Spritz RA. Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1) J Invest Dermatol 2010; 130(3): 774-83;","DOI":"10.1038\/jid.2009.273"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"D'Osualdo A, Reed JC. NLRP1, a regulator of innate immunity associated with vitiligo. Pigment Cell Melanoma Res 2012; 25(1): 5-8. doi: 10.1111\/j.1755-148X.2011.00942.x;","DOI":"10.1111\/j.1755-148X.2011.00942.x"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"M\u0119ci\u0144ska-Jundzi\u0142\u0142 K, Tadrowski T, Jundzi\u0142\u0142 A, Witmanowski H, Czajkowki R. Evaluation of polymorphisms and expression of PTPN22, NLRP1 and TYR genes in vitiligo patients. Postepy Dermatol Alergol 2023; 40(2): 225-33. doi: 10.5114\/ada.2023.126314;","DOI":"10.5114\/ada.2023.126314"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Li J, Yan M, Zhang Y, et al. Meta-analysis of the association between NLRP1 polymorphisms and the susceptibility to vitiligo and associated autoimmune diseases. Oncotarget 2017; 8: 88179-88;","DOI":"10.18632\/oncotarget.21165"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Deo S, Bhagat A, Shah R. Genetic variations in NALP1 MRNA expressions in human vitiligo. Indian J Dermatol 2011; 56: 266-71;","DOI":"10.4103\/0019-5154.82478"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, Holland PJ, Birlea SA, Siebert J, Hartmann A, Lienert A, van Geel N, Lambert J, Luiten RM, Wolkerstorfer A, Wietze van der Veen JP, Bennett DC, Ta\u00efeb A, Ezzedine K, Kemp EH, Gawkrodger DJ, Weetman AP, K\u00f5ks S, Prans E, Kingo K, Karelson M, Wallace MR, McCormack WT, Overbeck A, Moretti S, Colucci R, Picardo M, Silverberg NB, Olsson M, Valle Y, Korobko I, B\u00f6hm M, Lim HW, Hamzavi I, Zhou L, Mi QS, Fain PR, Santorico SA, Spritz RA. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet 2016; 48(11): 1418-24. doi: 10.1038\/ng.3680;","DOI":"10.1038\/ng.3680"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Rajendiran KS, Rajappa M, Chandrashekar L, Thappa DM. Association of PTPN22 gene polymorphism with nonsegmental vitiligo in South Indian Tamils. Postepy Dermatol Alergol 2018; 35(3): 280-5. doi: 10.5114\/ada.2018.76225;","DOI":"10.5114\/ada.2018.76225"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalised vitiligo. N Engl J Med 2010; 362: 1686-97;","DOI":"10.1056\/NEJMoa0908547"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Makova K, Norton H. Worldwide polymorphism at the MC1R locus and normal pigmentation variation in humans. Peptides 2005; 26(10): 1901-8. doi: 10.1016\/j.peptides.2004.12.032;","DOI":"10.1016\/j.peptides.2004.12.032"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Sz\u00e9ll M, Balt\u00e1s E, Bodai L, Bata-Cs\u00f6rgo Z, Nagy N, Dallos A, Pourfarzi R, Simics E, Kondorosi I, Szalai Z, T\u00f3th GK, Hunyadi J, Dobozy A, Kem\u00e9ny L. The Arg160Trp allele of melanocortin-1 receptor gene might protect against vitiligo. Photochem Photobiol 2008; 84(3): 565-71. doi: 10.1111\/j.1751-1097.2008.00296.x;","DOI":"10.1111\/j.1751-1097.2008.00296.x"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Dallos A, Pourfarzi R, Simics E, Kondorosi I, Szalai Z, T\u00f3th GK, Hunyadi J, Dobozy A, Kem\u00e9ny L. The Arg160Trp allele of melanocortin-1 receptor gene might protect against vitiligo. Photochem Photobiol. 2008; 84(3): 565-71. doi: 10.1111\/j.1751-1097.2008.00296.x;","DOI":"10.1111\/j.1751-1097.2008.00296.x"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Na GY, Lee KH, Kim MK, Lee SJ, Kim DW, Kim JC. Polymorphisms in the melanocortin-1 receptor (MC1R) and agouti signaling protein (ASIP) genes in Korean vitiligo patients. Pigment Cell Res. 2003; 16(4): 383-7. doi: 10.1034\/j.1600-0749.2003.00062.x;","DOI":"10.1034\/j.1600-0749.2003.00062.x"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Wan J, Lin F, Zhang W, Xu A, DeGiorgis J, Lu H, Wan Y. Novel approaches to vitiligo treatment via modulation of mTOR and NF-kB pathways in human skin melanocytes. Int J Biol Sci. 2017; 13(3): 391-400. doi: 10.7150\/ijbs.17318;","DOI":"10.7150\/ijbs.17318"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Xie Y, Wu N, Tang S, Zhou Z, Chen J, Li J, Wu F, Xu M, Xu X, Liu Y, Ma X. Endoplasmic Reticulum Dysfunction: An Emerging Mechanism of Vitiligo Pathogenesis. Clin Cosmet Investig Dermatol. 2024; 17: 1133-44. doi: 10.2147\/CCID.S459070;","DOI":"10.2147\/CCID.S459070"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Galv\u00e1n I, Jorge A, Garc\u00eda-Gil M. Pheomelanin molecular vibration is associated with mitochondrial ROS production in melanocytes and systemic oxidative stress and damage. Integr Biol (Camb) 2017; 9(9): 751-61. doi: 10.1039\/c7ib00107j;","DOI":"10.1039\/c7ib00107j"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Li S, Dai W, Wang S, Kang P, Ye Z, Han P, Zeng K, Li C. Clinical Significance of Serum Oxidative Stress Markers to Assess Disease Activity and Severity in Patients With Nonsegmental Vitiligo. Front Cell Dev Biol 2021; 9: 739413. doi: 10.3389\/fcell.2021.739413;","DOI":"10.3389\/fcell.2021.739413"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Agrawal S, Kumar A, Dhali TK, Majhi SK. Comparison of oxidant-antioxidant status in patients with vitiligo and healthy population. Kathmandu Univ Med J (KUMJ) 2014; 12(46): 132-6. doi: 10.3126\/kumj.v12i2.13660;","DOI":"10.3126\/kumj.v12i2.13660"},{"key":"ref47","unstructured":"Xiao BH, Shi M, Chen H, Cui S, Wu Y, Gao XH, Chen HD. Glutathione Peroxidase Level in Patients with Vitiligo: A Meta-Analysis. Biomed Res Int 2016; 2016: 3029810. doi: 10.1155\/2016\/3029810. Erratum in: Biomed Res Int 2017; 2017: 6707162. doi: 10.1155\/2017\/6707162;"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Mulayim MK, Kurutas EB, Nazik H, Ozturk P. Assessment of Oxidative\/Nitrosative Stress and Raftlin in Vitiligo. Indian J Dermatol 2022; 67(5): 624. doi: 10.4103\/ijd.ijd_917_20;","DOI":"10.4103\/ijd.ijd_917_20"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Lu L, Wu W, Tu Y, Yang Z, He L, Guo M. Association of glutathione S-transferase M1\/T1 polymorphisms with susceptibility to vitiligo. Gene 2014; 535(1): 12-6. doi: 10.1016\/j.gene.2013.11.024;","DOI":"10.1016\/j.gene.2013.11.024"},{"key":"ref50","unstructured":"G\u00f3mez-Meda BC, Z\u00fa\u00f1iga-Gonz\u00e1lez GM, Ba\u00f1uelos-D\u00edaz LD, Oceguera-Angel MP, Galindo-G\u00f3mez A, S\u00e1nchez-Parada MG, Garibaldi-R\u00edos AF, Torres-Mendoza BM, Zamora-Perez AL, Delgado-Saucedo JI, M\u00e1rquez-Rosales MG, Gallegos-Arreola MP. Association of SOD1 gene variants (50 bp Ins\/Del, rs4817415, rs2070424, rs1041740, rs17880135) with plasma protein levels in vitiligo patients and their analysis in silico. Eur Rev Med Pharmacol Sci 2024; 28(6): 2464-82. doi: 10.26355\/eurrev_202403_35752;"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Laddha NC, Dwivedi M, Gani AR, Shajil EM, Begum R. Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo. Free Radic Biol Med 2013; 65: 1110-25. doi: 10.1016\/j.freeradbiomed.2013.08.189;","DOI":"10.1016\/j.freeradbiomed.2013.08.189"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Ochoa-Ram\u00edrez LA, D\u00edaz-Camacho SP, Becerra-Loaiza DS, Verdugo-Nieto L, Mu\u00f1oz-Estrada VF, Serv\u00edn-V\u00e1zquez LA, Osuna-Ram\u00edrez I, Rodr\u00edguez-Mill\u00e1n J, Velarde-F\u00e9lix JS. Catalase but not vitamin D receptor gene polymorphisms are associated with nonsegmental vitiligo in Northwestern Mexicans. Int J Dermatol 2019; 58(11): 1264-9. doi: 10.1111\/ijd.14508;","DOI":"10.1111\/ijd.14508"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Lu L, Liu L, Ji Y, Jin H, He L. Association of the 389 C\/T polymorphism of the catalase gene with susceptibility to vitiligo: a meta-analysis. Clin Exp Dermatol 2014; 39(4): 454-60. doi: 10.1111\/ced.12340;","DOI":"10.1111\/ced.12340"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Lv YJ, Liao WJ, Luan Q, Wang H, Wang L, Li Q. The polymorphism of catalase T\/C codon 389 in exon 9 and vitiligo susceptibility: a meta-analysis. J Eur Acad Dermatol Venereol 2011; 25(8): 955-8. doi: 10.1111\/j.1468-3083.2010.03897.x;","DOI":"10.1111\/j.1468-3083.2010.03897.x"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Roberts GHL, Santorico SA, Spritz RA. Deep genotype imputation captures virtually all heritability of autoimmune vitiligo. Hum Mol Genet 2020; 29(5): 859-63. doi: 10.1093\/hmg\/ddaa005;","DOI":"10.1093\/hmg\/ddaa005"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Lu LY, Chen YT, Chen IL, Shih YC, Liu RT, Lai YJ, Ng CY. Feasibility of High-Cellular-Resolution Full-Field, Artificial-Intelligence-Assisted, Real-Time Optical Coherence Tomography in the Evaluation of Vitiligo: A Prospective Longitudinal Follow-Up Study. Bioengineering (Basel) 2024; 11(2): 196. doi: 10.3390\/bioengineering11020196;","DOI":"10.3390\/bioengineering11020196"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Roberts GHL, Paul S, Yorgov D, Santorico SA, Spritz RA. Family Clustering of Autoimmune Vitiligo Results Principally from Polygenic Inheritance of Common Risk Alleles. Am J Hum Genet 2019; 105(2): 364-72. doi: 10.1016\/j.ajhg.2019.06.013;","DOI":"10.1016\/j.ajhg.2019.06.013"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Cazzaniga S, Sassi F, Mercuri SR, Naldi L. Prediction of clinical response to excimer laser treatment in vitiligo by using neural network models. Dermatology 2009; 219(2): 133-7. doi: 10.1159\/000225934;","DOI":"10.1159\/000225934"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Otkrivanje genetske predispozicije i oksidativnog stresa u razvoju vitiliga i uloga ve\u0161ta\u010dke inteligencije (AI) u dijagnostici i le\u010denju"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582504713K.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T10:51:32Z","timestamp":1751626292000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582504713K"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-56661","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}